Published in J Immunol on May 01, 1990
Transcription factor complex formation and chromatin fine structure alterations at the murine c-fms (CSF-1 receptor) locus during maturation of myeloid precursor cells. Genes Dev (2002) 1.34
Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation. Mol Cell Biol (1993) 1.21
c-fos mRNA expression in macrophages is downregulated by interferon-gamma at the posttranscriptional level. Mol Cell Biol (1991) 0.98
Differential transcription factor occupancy but evolutionarily conserved chromatin features at the human and mouse M-CSF (CSF-1) receptor loci. Nucleic Acids Res (2003) 0.97
Differentiation of C2D macrophage cells after adoptive transfer. Clin Vaccine Immunol (2007) 0.85
The function of the conserved regulatory element within the second intron of the mammalian Csf1r locus. PLoS One (2013) 0.81
Administration of high-dose macrophage colony-stimulating factor increases bone turnover and trabecular volume fraction. J Bone Miner Metab (2009) 0.80
Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages. Immunology (1995) 0.77
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med (1995) 2.88
Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature (1986) 2.64
A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity (1997) 2.05
IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity (1998) 1.64
Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol (1988) 1.55
Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst (1989) 1.44
Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem (1997) 1.33
Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. Proc Natl Acad Sci U S A (1990) 1.31
A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage functions. Eur J Immunol (1987) 1.25
Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J Leukoc Biol (1991) 1.24
Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med (1990) 1.19
Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma. J Immunol (1995) 1.17
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 1.14
Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood (1990) 1.13
Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes. Cancer Res (1999) 1.12
Interferon activates macrophages to produce plasminogen activator. J Interferon Res (1982) 1.11
Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay. J Immunol Methods (1980) 1.10
Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect Immun (1990) 1.10
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun (1996) 1.08
Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ (2001) 1.08
Pleiotropic effects of transforming growth factor-beta on cells of the immune system. Ann N Y Acad Sci (1993) 1.05
Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J Immunol (1992) 1.05
Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism. Blood (1994) 1.05
IL-2 induces IL-6 production in human monocytes. J Immunol (1992) 1.03
IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol (1993) 1.02
Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2. Cancer Res (1989) 1.02
Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus. Cancer Biochem Biophys (1989) 1.01
Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cultured under hypoxic conditions. J Immunol (1996) 1.00
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut (2006) 0.99
Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblasts. Mol Cell Biol (1986) 0.99
c-fos mRNA expression in macrophages is downregulated by interferon-gamma at the posttranscriptional level. Mol Cell Biol (1991) 0.98
GILZ, a glucocorticoid hormone induced gene, modulates T lymphocytes activation and death through interaction with NF-kB. Adv Exp Med Biol (2001) 0.98
The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages. J Immunol (2000) 0.97
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood (1994) 0.97
Mechanisms of lymphocyte activation: linkage between early protein synthesis and late lymphocyte proliferation. J Immunol (1980) 0.97
Potent activation of mouse macrophages by recombinant interferon-gamma. Cancer Res (1984) 0.96
Macrophages as regulators of immune responses against tumors. Adv Exp Med Biol (1979) 0.96
Characterization of IL-2 receptor expression and function on murine macrophages. J Immunol (1990) 0.96
Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid. J Biol Chem (1994) 0.95
Augmentation of c-fos mRNA expression by activators of protein kinase C in fresh, terminally differentiated resting macrophages. Mol Cell Biol (1987) 0.93
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast Cancer Res Treat (2011) 0.93
A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells. J Biol Chem (1989) 0.93
The effect of cytochalasin B, colchicine and vinblastine on the adhesion of Trichomonas vaginalis to glass surfaces. Int J Parasitol (1975) 0.92
Interleukin-2 and human monocyte activation. J Leukoc Biol (1995) 0.90
Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines. Int J Cancer (1991) 0.90
An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells. Am J Physiol (1998) 0.90
Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Cancer Res (1987) 0.90
Inhibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biologic response modifiers. J Immunol (1988) 0.89
Lymphocyte traffic changes induced by monolateral vagal denervation in mouse thymus and peripheral lymphoid organs. J Neuroimmunol (1996) 0.88
Interferon-alpha, -beta, and -gamma augment the levels of rRNA precursors in peritoneal macrophages but not in macrophage cell lines and fibroblasts. J Immunol (1987) 0.87
Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. J Immunol (1993) 0.87
IL-2 enhances c-fms expression in human monocytes. J Immunol (1990) 0.86
Engineering of macrophages to produce IFN-gamma in response to hypoxia. J Immunol (2001) 0.86
Generation of a murine monoclonal antibody that detects the fos oncogene product. Anal Biochem (1987) 0.85
IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages. J Immunol (1991) 0.85
IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J Exp Med (1994) 0.85
In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA). J Immunopharmacol (1984) 0.85
Inhibition of replication of virus-transformed fibroblasts by antibodies to RNA. Cancer Res (1975) 0.85
Regulation by interleukin-2 (IL-2) and interferon gamma of IL-2 receptor gamma chain gene expression in human monocytes. Blood (1994) 0.84
Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells by activated macrophages. J Leukoc Biol (1986) 0.84
Glucocorticoid hormones in the regulation of cell death. Therapie (2000) 0.84
Functional role for the myeloid differentiation antigen CD14 in the activation of human monocytes by IL-2. J Immunol (1997) 0.84
Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma. J Immunol (1984) 0.84
Differential expression of CD44 isoforms during liver regeneration in rats. J Hepatol (2001) 0.84
Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor. Cancer Res (1979) 0.83
New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids. J Chromatogr B Biomed Sci Appl (2001) 0.83
IL-2 induction of IL-1 beta mRNA expression in monocytes. Regulation by agents that block second messenger pathways. J Immunol (1989) 0.83
Antiproliferative activity of picolinic acid due to macrophage activation. Drugs Exp Clin Res (1987) 0.83
IL-12 acts selectively on CD8 alpha- dendritic cells to enhance presentation of a tumor peptide in vivo. J Immunol (1999) 0.83
Role of protein synthesis in the activation of cytotoxic mouse macrophages by lymphokines. Cell Immunol (1984) 0.83
Regulation of IL-2 receptor subunit genes in human monocytes. Differential effects of IL-2 and IFN-gamma. J Immunol (1992) 0.83
Induction of macrophage glutamine: fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid. Int J Immunopathol Pharmacol (2007) 0.83
Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors. Int J Cancer (1981) 0.82
Human Harvey-ras is biochemically different from Kirsten- or N-ras. Oncogene (1991) 0.82
Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages. Cancer Res (1997) 0.82
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. Crit Rev Immunol (1998) 0.82
Selective inhibition by monosaccharides of tumor cell cytotoxicity mediated by mouse macrophages, macrophage-like cell lines, and natural killer cells. Int J Cancer (1983) 0.82
Distribution of peritoneal macrophage populations after intravenous injection in mice: differential effects of eliciting and activating agents. J Reticuloendothel Soc (1983) 0.82
Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon. Cell Immunol (1981) 0.82
Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines. J Immunol (1980) 0.82
Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur J Immunol (1999) 0.81
Bryostatin-1 and IL-2 synergize to induce IFN-gamma expression in human peripheral blood T cells: implications for cancer immunotherapy. J Immunol (2001) 0.81
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J Immunol (1997) 0.81
Protein kinase C inhibitors block the activation of macrophages by IFN-beta but not by IFN-gamma. J Immunol (1988) 0.81
IL-2 signaling in human monocytes involves the phosphorylation and activation of p59hck. J Immunol (2000) 0.80
Modulation of CD3- large granular lymphocyte functions by agonist and antagonists of protein kinase C: effects on NK and lymphokine-activated killer activity and production of IFN-gamma. J Immunol (1989) 0.80
Immortalization of macrophages from mouse bone marrow and fetal liver. Exp Cell Res (1990) 0.80
Prostaglandins inhibit lipoprotein lipase gene expression in macrophages. Immunology (1994) 0.80
In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation. J Immunol (1981) 0.79
Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production. Cell Immunol (1980) 0.79